Beijing Genotype of Tuberculosis and Treatment Outcomes in Vietnam
Author Information
Author(s): Lan Nguyen Thi Ngoc, Lien Hoang Thi Kim, Tung Le B., Borgdorff Martien W., Kremer Kristin, van Soolingen Dick
Primary Institution: Pham Ngoc Thach Tuberculosis and Lung Diseases Centre, Ho Chi Minh City, Vietnam
Hypothesis
Is the Beijing genotype a risk factor for treatment failure and relapse in tuberculosis patients?
Conclusion
The Beijing genotype is a significant risk factor for treatment failure and relapse in tuberculosis patients in Vietnam.
Supporting Evidence
- The Beijing genotype was associated with treatment failure (OR 3.3) and relapse (OR 2.4).
- 40 of 125 case-patients whose treatment failed had nearly identical RFLP patterns.
- 2,568 out of 2,901 enrolled patients recovered, while 125 experienced treatment failure.
Takeaway
This study found that a specific type of tuberculosis bacteria, called the Beijing genotype, makes it more likely for patients to not get better or to get sick again after treatment.
Methodology
The study enrolled 2,901 new smear-positive tuberculosis patients and analyzed their treatment outcomes and bacterial genotypes.
Potential Biases
The selection of controls may introduce bias, as the study had a limited number of case-patients.
Limitations
The study had limited power to detect risk factors due to the relatively small numbers of case-patients experiencing treatment failure and relapse.
Participant Demographics
Slightly more men than women were enrolled, and enrollment was low in those over 65 years of age.
Statistical Information
P-Value
p < 0.01 for treatment failure, p < 0.05 for relapse
Confidence Interval
95% CI 1.5 to 5.2
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website